Changes in blood metabolomes as potential biomarkers for severity and prognosis in doxorubicin-induced heart failure: a study in HER2-positive and HER2-negative breast cancer patients

Back

ESC Premium Access

Changes in blood metabolomes as potential biomarkers for severity and prognosis in doxorubicin-induced heart failure: a study in HER2-positive and HER2-negative breast cancer patients

Session: Cardiomyopathies uncovered

Topic: Cardiotoxicity of Drugs and Other Therapies

Speaker: Associate Professor C. Thonusin (Chiang Mai, TH)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Associate Professor Chanisa Thonusin

Chiang Mai University, Chiang Mai (Thailand)

0 follower

5 more presentations in this session

Fabry cardiomyopathy: myocardial fibrosis, inflammation and reduced mannose6phosphate receptors cause low accessibility to enzyme therapy.

Speaker: Associate Professor A. Frustaci (Rome, IT)

Global and national insights into the decline of hypertrophic cardiomyopathy as a cause of sudden death in the young

Speaker: Doctor D. Nelson (Melbourne, AU)

Proteomic profiling of extracellular vesicles in takotsubo syndrome

Speaker: Mr E. Zulfaj (Gothenburg, SE)

Clinical validated risk prediction model for development of heart failure after contemporary breast cancer treatment

Speaker: Professor A. Barac (Falls Church, US)

Association of genetically predicted human metabolomic gene expression with incident heart failure

Speaker: Mr H. Ahn (London, GB)

Access the full session

Cardiomyopathies uncovered

Speakers: Associate Professor C. Thonusin, Associate Professor A. Frustaci, Doctor D. Nelson, Mr E. Zulfaj, Professor A. Barac...

Access

Video

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources